Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D M Coulter

Showing results (1-10 of 46) with videos related to

Pageof 5
Sort By:
The New Zealand Medical Journal|February 11, 1981
Study of reasons for cessation of therapy with perhexiline maleate, sodium valproate and labetalol in the intensified adverse reaction reporting schemeD M Coulter
British Medical Journal (Clinical Research Ed.)|April 16, 1988
Eye pain with nifedipine and disturbance of taste with captopril: a mutually controlled study showing a method of postmarketing surveillanceD M Coulter
Pharmacoepidemiology and Drug Safety|April 10, 2004
The New Zealand Intensive Medicines Monitoring ProgrammeD M Coulter
The New Zealand Medical Journal|November 14, 1979
A comparison of scalp tingling, thirst and polyuria in patients on labetalol and metoprololD M Coulter
Pharmacoepidemiology and Drug Safety|November 26, 2008
The New Zealand intensive medicines monitoring programme in pro-active safety surveillanceD M Coulter
The New England Journal of Medicine|March 7, 1991
Maternal age and outcome of pregnancy (continued)D M Coulter
Pediatric Research|August 1, 1983
Prolactin: a hormonal regulator of the neonatal tissue water reservoirD M Coulter
The New Zealand Medical Journal|February 13, 1991
Trial of slow release diltiazem for essential hypertension in general practiceD M Coulter
Pharmacoepidemiology and Drug Safety|May 1, 2002
Privacy issues and the monitoring of sumatriptan in the New Zealand Intensive Medicines Monitoring ProgrammeD M Coulter
The Journal of Pediatrics|April 1, 1992
Use of fentanyl in neonatesD M Coulter
Pageof 5

Showing results (1-10 of 46) with videos related to

Sort By:
Pageof 5
The New Zealand Medical Journal|February 11, 1981
Study of reasons for cessation of therapy with perhexiline maleate, sodium valproate and labetalol in the intensified adverse reaction reporting schemeD M Coulter
British Medical Journal (Clinical Research Ed.)|April 16, 1988
Eye pain with nifedipine and disturbance of taste with captopril: a mutually controlled study showing a method of postmarketing surveillanceD M Coulter
Pharmacoepidemiology and Drug Safety|April 10, 2004
The New Zealand Intensive Medicines Monitoring ProgrammeD M Coulter
The New Zealand Medical Journal|November 14, 1979
A comparison of scalp tingling, thirst and polyuria in patients on labetalol and metoprololD M Coulter
Pharmacoepidemiology and Drug Safety|November 26, 2008
The New Zealand intensive medicines monitoring programme in pro-active safety surveillanceD M Coulter
The New England Journal of Medicine|March 7, 1991
Maternal age and outcome of pregnancy (continued)D M Coulter
Pediatric Research|August 1, 1983
Prolactin: a hormonal regulator of the neonatal tissue water reservoirD M Coulter
The New Zealand Medical Journal|February 13, 1991
Trial of slow release diltiazem for essential hypertension in general practiceD M Coulter
Pharmacoepidemiology and Drug Safety|May 1, 2002
Privacy issues and the monitoring of sumatriptan in the New Zealand Intensive Medicines Monitoring ProgrammeD M Coulter
The Journal of Pediatrics|April 1, 1992
Use of fentanyl in neonatesD M Coulter
Pageof 5